CareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease Portfolio
The issuer is solely responsible for the content of this announcement.
The issuer is solely responsible for the content of this announcement.